TELEDYNE TECHNOLOGIES INC
Biopharma roundup reported FDA/EC approvals and trial updates for Lantheus (LNTH) TAUKLARIFY, Ceribell (CBLL) AI EEG algorithms, Labcorp (LH) PGDx CDx, and EU/UK approvals for Galderma (GDERF) Restylane Shaype and Rhythm (RYTM) IMCIVREE. GRAIL (GRAL) faces an FDA panel on Sept. 23. Teledyne (TDY) to buy Varex (VREX) for about $1.1B; Aura (AURA) cut 20% staff.
Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.
Teledyne Technologies agreed to acquire all outstanding shares of Varex Imaging under a definitive deal approved unanimously by both boards. Varex makes X-ray sources and digital detectors plus imaging software for medical and industrial inspection. The deal is expected to close in early 2027, pending regulatory and Varex stockholder approval.
Over the past 7 days, alphai's AI scored 21 news stories mentioning TDY (TELEDYNE TECHNOLOGIES INC). Coverage has skewed bullish: 17 bullish, 4 neutral, and 0 bearish.
Recent TDY coverage spans mergers & acquisitions, financial news and insider activity.
In the last 30 days, TDY insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($4.7M). The most active reporter was LORNE SIMON M with 4 filings.
Definitive acquisition terms provide a clear M&A catalyst for Teledyne, including deal-spread and integration expectations.
Deal premium and narrow implied spread suggest investors are weighing return on capital and deal execution risk rather than immediate value destruction.
Deal announcement is a near-term catalyst for TDY sentiment and deal-spread dynamics, with execution and regulatory approvals as key swing factors into 2027.
Deal announcement is a direct catalyst for TDY risk and valuation, with closing targeted for early 2027 and subject to regulatory and stockholder approvals.
This is a routine insider open-market sale under a director’s direct holdings, with no 10b5-1 plan disclosed.
alphai scores every news story that mentions TDY with an AI model for sentiment and relevance, and aggregates insider trades from TELEDYNE TECHNOLOGIES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Biopharma roundup reported FDA/EC approvals and trial updates for Lantheus (LNTH) TAUKLARIFY, Ceribell (CBLL) AI EEG algorithms, Labcorp (LH) PGDx CDx, and EU/UK approvals for Galderma (GDERF) Restylane Shaype and Rhythm (RYTM) IMCIVREE. GRAIL (GRAL) faces an FDA panel on Sept. 23. Teledyne (TDY) to buy Varex (VREX) for about $1.1B; Aura (AURA) cut 20% staff.
7 min readTeledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.
6 min readTeledyne Technologies agreed to acquire all outstanding shares of Varex Imaging under a definitive deal approved unanimously by both boards. Varex makes X-ray sources and digital detectors plus imaging software for medical and industrial inspection. The deal is expected to close in early 2027, pending regulatory and Varex stockholder approval.
3 min readTeledyne Technologies agreed to acquire Varex Imaging in a cash deal for $18.90 per Varex share, valuing the transaction at about $1.1 billion including equity awards and net debt as of April 3, 2026. Boards approved unanimously. Closing is expected in early 2027, pending regulatory and Varex stockholder approvals.
4 min readVON SCHACK WESLEY W sold 468 shares of TELEDYNE TECHNOLOGIES INC (TDY) at $686.63 ($0.32M total) on 2026-08-12.
2 min readFitch Ratings upgraded Teledyne Technologies Inc. (NYSE:TDY) long-term issuer default rating to BBB+ from BBB and raised its senior unsecured revolver and notes to BBB+ from BBB, with a Stable outlook. Fitch cited stronger free cash flow, low 2.0x EBITDA leverage, debt near $2.0B, and funded backlog about $5.0B. Fitch also referenced TDY’s $1.1B acquisition of Varex Imaging.
4 min readVarex Imaging (NASDAQ:VREX) agreed to be acquired by Teledyne Technologies (NYSE:TDY) for $18.90 per share in a cash deal valued at about $1.1 billion, including Varex equity awards and net debt. Boards approved; close expected early 2027 after shareholder and regulatory approvals. Varex completed a $490 million refinancing in March 2026.
6 min readTeledyne Technologies’ Teledyne DALSA announced the Falcon4-CLHS M8200-Scientific, a new 67 MP area scan camera for life sciences and scientific imaging. It uses a customized Emerald 67 MP CMOS sensor and targets low read noise (~3 e-), up to 64 dB dynamic range, and pixel-level factory calibration. The camera is available now.
3 min readLORNE SIMON M sold 6,449 shares of TELEDYNE TECHNOLOGIES INC (TDY) at an average of $680.34 ($679.74–$682.81, $4.39M total) across 4 trades on 2026-08-12.
1 min readTeledyne FLIR Defense said it has manufactured and shipped its 3,000th Ranger surveillance radar system from its Laval, Quebec facility. The Ranger radars are deployed in more than 40 countries, and the company noted a 2024 software upgrade adding 360-degree Fast Scan, higher refresh rates, earlier threat warnings, and AI-enabled processing. Teledyne Technologies (NYSE:TDY) owns the unit.
2 min read
